fbpx

Non Invasive Prenatal Testing (NIPT)

Non Invasive Prenatal Testing (NIPT)

All pregnant women are concerned about the health of their fetus and possibility of genetic abnormalities. Non Invasive Prenatal Testing (NIPT) is a convenient option to screen for chromosomal abnormalities in fetus using maternal blood. The test can be performed after 10 weeks of pregnancy and requires a simple blood draw. It offers higher sensitivity and specificity as compared with the traditional biochemical and ultrasound based screening options.

Leveraging the Power of Latest Technologies

This test is based on sequencing technology where the maternal blood is sequenced and the cell free fetal DNA fragments (cfDNA) floating in the maternal blood are analyzed to estimate the risks for chromosomal abnormalities

Easy (A Simple Blood Draw)

NIPT involves a simple blood draw anytime after 10 weeks of gestation. The test is based on next generation sequencing (NGS) technology where the cell-free fetal DNA floating in the mother’s blood stream is analyzed and the chromosomal anomalies are predicted.

Secure (No Risks of Miscarriage)

Unlike any invasive diagnostic procedure which involve a small risk of miscarriage, the NIPT test is far more convenient with minimal risks associated with prenatal testing and yet offering a higher accuracy for screening of genetic abnormalities as compared to an ultrasound scan.

Reassuring (More Effective than Routine Testing)

NIPT method is known to offer far greater sensitivity as compared to other prenatal testing methods. It is hence more reassuring to the expecting parents and the doctors.

Labassure Advantage

*HARMONY is a trademark of Roche

Quick Links